Shelley Chu

Shelley Chu

Direktor/Vorstandsmitglied bei ODYSSEY THERAPEUTICS, INC.

Vermögen: 207 887 $ am 30.06.2026

56 Jahre
Health Technology
Finance
Commercial Services

Profil

Shelley Chu is currently an Independent Director at Odyssey Therapeutics, Inc. since 2025.
Current roles also include Director positions at Alpha-9 Oncology, Inc., Diagonal Therapeutics, Inc., Zag Bio, Inc., SFJ Pharmaceuticals, Inc., Antares Therapeutics, Inc., 3T Biosciences, Inc., ImmunOs Therapeutics AG, Adanate, Inc., Q32 Bio Operations, Inc., Protego Biopharma, Inc., IFM Cinque, Inc., IFM Continua, Inc., IFM Quattro, Inc., TRIANA Biomedicines, Inc., Medikine, Inc., Trishula Therapeutics, Inc., Enlaza Therapeutics, Inc., Ifm Therapeutics, Inc., Abata Therapeutics, Inc., IFM Due, Inc., and Seismic Therapeutic, Inc. since 2022.
A Partner at Lightspeed Management Co LLC since 2020.
Former roles include Director at Kalidex Pharmaceuticals, Inc., Venatorx Pharmaceuticals, Inc., Scorpion Therapeutics, Inc., Tizona Therapeutics, Inc., Phathom Pharmaceuticals, Inc., Novartis Inflammasome Research, Inc., and Partner at Abingworth LLP and Abingworth Management, Inc. Senior Director-R&D Strategy at Gilead Pharmasset LLC from 2012 to 2015.
Independent Director at HilleVax, Inc. from 2021 to 2025.
Principal at Frazier Management LLC and Flagship Pioneering, Inc. from 2002 to 2005.
Education includes undergraduate studies at Princeton University and a doctorate from The University of California, San Francisco.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
11.05.2026 11.111 ( 0,02 % ) 207 887 $ 30.06.2026

Aktive Positionen von Shelley Chu

UnternehmenPositionBeginn
ODYSSEY THERAPEUTICS, INC. Direktor/Vorstandsmitglied 01.08.2025
Direktor/Vorstandsmitglied 10.02.2022
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Shelley Chu

UnternehmenPositionEnde
HILLEVAX, INC. Direktor/Vorstandsmitglied 17.09.2025
░░░░░░ ░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ -
░░░░░░░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░ ░░░░░░ ░░░░░░░░ -
Sehen Sie sich die Erfahrung von Shelley Chu im Detail an

Ausbildung von Shelley Chu

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

40

Beziehungen ersten Grades

34

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen34

Finance

Health Technology

Health Technology

Finance

Finance

Finance

Consumer Services

Consumer Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Technology Services

Health Technology

  1. Börse
  2. Insiders
  3. Shelley Chu